A detailed history of Compass Ion Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Compass Ion Advisors, LLC holds 23,450 shares of MRK stock, worth $2.28 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
23,450
Previous 23,336 0.49%
Holding current value
$2.28 Million
Previous $2.89 Million 7.83%
% of portfolio
0.35%
Previous 0.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$111.15 - $128.97 $12,671 - $14,702
114 Added 0.49%
23,450 $2.66 Million
Q1 2024

Apr 17, 2024

SELL
$113.24 - $131.95 $17,212 - $20,056
-152 Reduced 0.65%
23,336 $3.08 Million
Q4 2023

Jan 23, 2024

BUY
$100.18 - $109.02 $169,905 - $184,897
1,696 Added 7.78%
23,488 $2.56 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $1.93 Million - $2.14 Million
18,709 Added 606.84%
21,792 $2.24 Million
Q2 2023

Aug 11, 2023

SELL
$108.61 - $118.38 $137,174 - $149,513
-1,263 Reduced 29.06%
3,083 $355,000
Q1 2023

Apr 17, 2023

BUY
$102.94 - $114.86 $4,323 - $4,824
42 Added 0.98%
4,346 $462,000
Q4 2022

Jan 17, 2023

BUY
$87.44 - $112.11 $13,640 - $17,489
156 Added 3.76%
4,304 $0
Q3 2022

Oct 18, 2022

BUY
$84.53 - $94.96 $350,630 - $393,894
4,148 New
4,148 $357,000
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $300,500 - $333,494
-4,187 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $33,882 - $38,405
463 Added 12.43%
4,187 $347,000
Q2 2020

Jul 09, 2020

SELL
$70.42 - $80.13 $3,168 - $3,605
-45 Reduced 1.19%
3,724 $288,000
Q1 2020

Apr 09, 2020

BUY
$63.36 - $87.82 $26,231 - $36,357
414 Added 12.34%
3,769 $290,000
Q4 2019

Jan 17, 2020

BUY
$77.58 - $87.54 $260,280 - $293,696
3,355 New
3,355 $305,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Compass Ion Advisors, LLC Portfolio

Follow Compass Ion Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Ion Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Ion Advisors, LLC with notifications on news.